Low-cholesterol diet and antilipid therapy in managing tinnitus and hearing loss in patients with noise-induced hearing loss and hyperlipidemia

International Tinnitus Journal

Volumn 13, Issue 2, 2007, Pages 143-149

  Sutbas, Aziz ^a   Yetiser, Sertac ^a   Satar, Bulent ^a   Akcam, Timur ^a   Karahatay, Serdar ^a   Saglam, Kenan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antilipid therapy; Hyperlipidemia; Low cholesterol diet; Noise induced hearing loss; Tinnitus

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AIR CONDUCTION; AUDITORY THRESHOLD; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; HEARING LOSS; HUMAN; HYPERLIPIDEMIA; MALE; NOISE; NOISE INJURY; NOISE POLLUTION; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; TINNITUS; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTICHOLESTEREMIC AGENTS; FEMALE; HEARING LOSS, NOISE-INDUCED; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TINNITUS;

EID: 37549048227     PISSN: 09465448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (43)

1. Moller AR. Pathophysiology of tinnitus. Ann Otol Rhinol Laryngol 93:39-44, 1984.
2. Nicolas-Puel C, Faulconbridge RL, Guitton M, et al. A. Characteristics of tinnitus and etiology of associated hearing loss: A study of 123 patients. Int Tinnitus J 8(1):37-44, 2002.
3. Pyykko I, Koskimies K, Starck J, et al. Risk factor in the genesis of sensorineural hearing loss in Finnish forestry workers. Br J Ind Med 46(7):439-446, 1989.
4. Gold S, Haran I, Attias J, et al. Biochemical and cardiovascular measures in subjects with noise-induced hearing loss. J Occup Med 31(11):933-937, 1989.
5. Toppila E, Pyyko I, Starck J, et al. Individual risk factors in the development of noise-induced hearing loss. Noise Health 2(8):59-70, 2000.
6. Scheibe F, Haupt H, Baumgartl H. Effects of experimental cochlear thrombosis on oxygenation: Auditory function of the inner ear. Eur Arch Otorhinolaryngol 254(2):91-94, 1997.
7. Clerici WJ, Yang L. Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function. Hear Res 101:14-22, 1996.
8. Hildesheimer M, Rubinstein M, Nuttal AL, Lawrence M. Influence of blood viscosity on cochlear action potentials and oxygenation. Hear Res 8:187-198, 1982.
9. Suckfull M, Thiery J, Schorn K, et al. Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: A prospective, randomized study. Acta Otolaryngol 119(7):763-766, 1999.
10. Gratton MA, Wright CG. Alteration of ear morphology in experimental hypercholesterolemia. Hear Res 61:97-105, 1992.
11. Gates GA, Cobb JL, D'Agostino RB, Wolf PA. The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg 119(2):156-161, 1993.
12. Lowry LD, Isaacson SR. Study of 100 patients with bilateral sensorineural hearing loss for lipid abnormalities. Ann Otol 87:404-408, 1978.
13. Lim D. Effects of noise and ototoxic drugs at the cellular level in the cochlea. Am J Otolaryngol 7:73-99, 1988.
14. Yamane H, Nakai Y, Takayama M, et al. Appearance of free radicals in the guinea pig inner ear after noise-induced acoustic trauma. Arch Otorhinolaryngol 252:504-508, 1995.
15. Ohlemiller KK, Wright JS, Dugan LL. Early elevation of cochlear reactive oxygen species following noise exposure. Audiol Neurootol 4:229-236, 1999.
16. Ohinata Y, Miller JM, Altschuler RA, Schacht J. Intense noise induces formation of vasoactive lipid peroxidation products in the cochlea. Brain Res 878:163-173, 2000.
17. Satar B, Ozkaptan Y, Surucu HS, Ozturk H. Ultrastructural effects of hypercholesterolemia on the cochlea. Otol Neurotol 22(6):786-789, 2001.
18. Rosen S, Olin P. Hearing loss and coronary heart disease. Arch Otolaryngol 82:236-243, 1965.
19. Spencer JT. Hyperlipoproteinemia in the etiology of inner ear. Laryngoscope 83:639-678, 1973.
20. Friedrich G, Pilger E. Lipoproteins in cochleovestibular disorders. Arch Otorhinolaryngol 232:101-105, 1981.
21. Pyykko I, Koskimies K, Starck J, et al. Evaluation of factors affecting sensory-neural hearing loss. Acta Otolaryngol 449:155-158, 1988.
22. Strome M, Topf P, Vernick DM. Hyperlipidemia in association with childhood sensorineural hearing loss. Laryngoscope 98:165-169, 1988.
23. Suzuki K, Kanek M, Murai K. Influence of serum lipids on auditory function. Laryngoscope 110:1736-1738, 2000.
24. Cunningham DR, Goetzinger CP. Extra-high frequency hearing loss and hyperlipidemia. Audiology 13:470-484, 1974.
25. Pruszewicz A, Kruk-Zagajewska A, Szyfter W, Smolinska K. Lipid levels in patients with sudden deafness of unknown etiology. Audiology 22:63-72, 1983.
26. Booth JB. Hyperlipidemia and deafness: A preliminary survey. Proc R Soc Med 70:642-646, 1977.
27. Pulec JL, Pulec MB, Mendoza I. Progressive sensorineural hearing loss, subjective tinnitus and vertigo caused by elevated blood lipids. Ear Nose Throat J 77(10):716-728, 1997.
28. Ben-David J, Pratt H, Landman L, et al. A comparison of auditory brainstem evoked potentials in hyperlipidemic and normolipidemic subjects. Laryngoscope 96:186-189, 1986.
29. Saito T, Sato K, Saito H. An experimental study of auditory dysfunction associated with hyperlipoproteinemia. Arch Otorhinolaryngol 243:242-245, 1986.
30. Morizono T, Paparella MM. Hypercholesterolemia and auditory dysfunction. Experimental studies. Ann Otol 87:804-814, 1978.
31. Preyer S, Baisch A, Bless D, Gummer AW. Distortion product otoacoustic emissions in human hypercholesterolemia. Hear Res 152:139-151, 2001.
32. Erdem T, Ozturan O, Miman MC, et al. Exploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissions. Eur Arch Otorhinolaryngol 260(2):62-66, 2003.
33. Nguyen TV, Brownell WE. Contribution of membrane cholesterol to outer hair cell lateral wall stiffness. Otolaryngol Head Neck Surg 119:14-20, 1998.
34. Axelsson A, Lindgren F. Is there a relationship between hypercholesterolemia and hearing loss? Acta Otolaryngol 100:379-386, 1985.
35. Morizono T, Sikora MA. Experimental hypercholesterolemia and auditory function in the chinchilla. Otolaryngol Head Neck Surg 90:814-818, 1982.
36. Sikora MA, Morizono T, Ward WD, et al. Diet-induced hyperlipidemia and auditory dysfunction. Acta Otolaryngol 102:372-381, 1986.
37. Pillsbury HC. Hypertension, hyperlipoproteinemia, chronic noise exposure: Is there a synergism in cochlear pathology? Laryngoscope 96:1112-1138, 1986.
38. Tami TA, Fankhauser CE, Mehlum DL. Effects of noise exposure and hypercholesterolemia on auditory function in the New Zealand white rabbit. Otolaryngol Head Neck Surg 93:235-239, 1985.
39. Rosen S, Olin P, Rosene HV. Dietary prevention of hearing loss. Acta Otolaryngol 70:242-247, 1970.
40. Henry KR. Effects of dietary restriction on presbycusis in the mouse. Audiology 25:329-337, 1986.
41. Sweet RJ, Price JM, Henry KR. Dietary restriction and presbycusis periods of restriction and auditory threshold losses in the CBA/J mouse. Audiology 27:305-312, 1988.
42. Kojima Y, Ito S, Furuya N. Hearing improvement after therapy for hyperlipidemia in patients with chronic-phase sudden deafness. Ann Otol Rhinol Laryngol 110:105-108, 2001.
43. Jones NS, Davis A. A prospective case-controlled study of 197 men, 50-60 years old, selected at random from a population at risk from hyperlipidemia to examine the relationship between hyperlipidemia and sensorineural hearing loss. Clin Otolaryngol 24:449-456, 1999.